Source:http://linkedlifedata.com/resource/pubmed/id/20445534
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
6
|
pubmed:dateCreated |
2010-5-20
|
pubmed:abstractText |
Nonsteroidal anti-inflammatory drugs (NSAIDs), other than aspirin, are to some extent metabolized by cytochrome P450 2C9 (CYP2C9). The CYP2C9 359Leu (CYP2C9*3) loss-of-function allele could be a risk factor for acute upper gastrointestinal bleeding (AUGIB) related to the use of NSAIDs other than aspirin. To test this hypothesis, we performed a prospective, multicenter, case-case study in patients hospitalized for AUGIB related to the use of NSAIDs. A total of 131 patients had been treated with aspirin and 57 patients had been treated with an NSAID other than aspirin (non-ASP). In the aspirin group, 12 patients (9.2%) had the CYP2C9 359Leu allele as compared with 19 (33.3%) in the non-ASP group (odds ratio (OR) = 5.0; 95% confidence interval 2.2-11.1, P < 0.0001). In a multivariate analysis, CYP2C9 359Leu remained associated with the non-ASP group (OR = 7.2 (2.6-20.3), P = 0.0002) even though 40% of these patients were under treatment with antiulcer drugs at the time of admission. Therefore the results of the study support the hypothesis that the CYP2C9 359Leu allele is a robust risk factor for AUGIB related to the use of NSAIDs other than aspirin.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Anti-Inflammatory Agents...,
http://linkedlifedata.com/resource/pubmed/chemical/Anti-Ulcer Agents,
http://linkedlifedata.com/resource/pubmed/chemical/Aryl Hydrocarbon Hydroxylases,
http://linkedlifedata.com/resource/pubmed/chemical/Aspirin,
http://linkedlifedata.com/resource/pubmed/chemical/CYP2C9 protein, human
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
1532-6535
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:volume |
87
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
693-8
|
pubmed:meshHeading |
pubmed-meshheading:20445534-Aged,
pubmed-meshheading:20445534-Aged, 80 and over,
pubmed-meshheading:20445534-Alleles,
pubmed-meshheading:20445534-Anti-Inflammatory Agents, Non-Steroidal,
pubmed-meshheading:20445534-Anti-Ulcer Agents,
pubmed-meshheading:20445534-Aryl Hydrocarbon Hydroxylases,
pubmed-meshheading:20445534-Aspirin,
pubmed-meshheading:20445534-Case-Control Studies,
pubmed-meshheading:20445534-Female,
pubmed-meshheading:20445534-Gastrointestinal Hemorrhage,
pubmed-meshheading:20445534-Humans,
pubmed-meshheading:20445534-Male,
pubmed-meshheading:20445534-Middle Aged,
pubmed-meshheading:20445534-Multivariate Analysis,
pubmed-meshheading:20445534-Prospective Studies,
pubmed-meshheading:20445534-Risk Factors
|
pubmed:year |
2010
|
pubmed:articleTitle |
CYP2C9*3 Loss-of-Function Allele Is Associated With Acute Upper Gastrointestinal Bleeding Related to the Use of NSAIDs Other Than Aspirin.
|
pubmed:affiliation |
Hepatology Department, Assistance Publique Hôpitaux de Paris, Saint-Antoine Hospital, University Pierre et Marie Curie, Paris, France.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Multicenter Study
|